NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas.
Sehgal P, Naqvi AS, Higgins M, Liu J, Harvey K, Jarroux J, Kim T, Mankaliye B, Mishra P, Watterson G, Fine J, Davis J, Hayer KE, Castro A, Mogbo A, Drummer C 4th, Martinez D, Koptyra MP, Ang Z, Wang K, Farrel A, Quesnel-Vallieres M, Barash Y, Spangler JB, Rokita JL, Resnick AC, Tilgner HU, De Raedt T, Powell DJ Jr, Thomas-Tikhonenko A.
Sehgal P, et al. Among authors: spangler jb.
Cell Rep. 2025 Aug 26;44(8):116099. doi: 10.1016/j.celrep.2025.116099. Epub 2025 Aug 7.
Cell Rep. 2025.
PMID: 40782352
Free PMC article.